{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:07:50Z","timestamp":1793275670240,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["LRAP 24"],"award-info":[{"award-number":["LRAP 24"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["LRAP 24"],"award-info":[{"award-number":["LRAP 24"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","award":["LRAP 24"],"award-info":[{"award-number":["LRAP 24"]}],"id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"RCUK | Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["EP\/Z536143\/1"],"award-info":[{"award-number":["EP\/Z536143\/1"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Chem."],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chemically modified nucleic acids such as antisense oligonucleotides, small interfering RNA and CRISPR guide RNA have emerged as transformative modalities in modern medicine, providing new strategies for the treatment of genetic and metabolic disorders, viral infections and cancer. However, their application is limited by challenges related to intracellular delivery and targeting, advances in which would benefit from a broader range of methods for chemical functionalization. Here we describe a streamlined approach using inexpensive, bench-stable alcohols or nucleosides that enables site-selective modification at the 5\u2032 and 3\u2032 termini and at internal sites of synthetic oligonucleotides. Our strategy offers a conceptually straightforward solution to this problem through the in situ generation of phosphoramidites on the solid-supported oligonucleotide. The methodology displays high coupling efficiency, high functional-group compatibility with azides, amines and thiols, and efficient recovery of excess alcohols\/monomers, thus offering a robust platform for advancing and diversifying therapeutic oligonucleotide modification.<\/jats:p>","DOI":"10.1038\/s41557-026-02214-6","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:01:59Z","timestamp":1784710919000},"page":"1747-1754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A versatile strategy for oligonucleotide functionalization via on-support phosphitylation"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9945-8334","authenticated-orcid":false,"given":"Ayan","family":"Dasgupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1117-3401","authenticated-orcid":false,"given":"Sebastian","family":"Golojuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0248-7871","authenticated-orcid":false,"given":"Li","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour Eddine","family":"Fahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4149-0494","authenticated-orcid":false,"given":"Edward A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6538-3036","authenticated-orcid":false,"given":"Tom","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"2214_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102440","volume":"36","author":"S Naeem","year":"2025","unstructured":"Naeem, S., Zhang, J., Zhang, Y. & Wang, Y. Nucleic acid therapeutics: past, present, and future. Mol. Ther. Nucleic Acids 36, 102440 (2025).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2214_CR2","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/nar\/gkx1239","volume":"46","author":"X Shen","year":"2018","unstructured":"Shen, X. & Corey, D. R. Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs. Nucleic Acids Res. 46, 1584\u20131600 (2018).","journal-title":"Nucleic Acids Res."},{"key":"2214_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s42004-025-01631-x","volume":"8","author":"H Yokoe","year":"2025","unstructured":"Yokoe, H. et al. Chemical autoligation with phosphorothioate- and sulfonamide-terminated DNA via intramolecular cross-activation. Commun. Chem. 8, 232 (2025).","journal-title":"Commun. Chem."},{"key":"2214_CR4","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1038\/s41591-024-03217-x","volume":"30","author":"R Schuele","year":"2024","unstructured":"Schuele, R., Synofzik, M., Graessner, H. & Aartsma-Rus, A. Advancing ASO therapies from development to implementation. Nat. Med. 30, 2725\u20132726 (2024).","journal-title":"Nat. Med."},{"key":"2214_CR5","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1056\/NEJMoa1913805","volume":"382","author":"FJ Raal","year":"2020","unstructured":"Raal, F. J. et al. Inclisiran for the treatment of heterozygous familial hypercholesterolemia. N. Engl. J. Med. 382, 1520\u20131530 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2214_CR6","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/nar\/gkad067","volume":"51","author":"M Egli","year":"2023","unstructured":"Egli, M. & Manoharan, M. Chemistry, structure and function of approved oligonucleotide therapeutics. Nucleic Acids Res. 51, 2529\u20132573 (2023).","journal-title":"Nucleic Acids Res."},{"key":"2214_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-024-02112-8","volume":"10","author":"M Liu","year":"2025","unstructured":"Liu, M. et al. Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines. Signal Transduct. Targeted Ther. 10, 73 (2025).","journal-title":"Signal Transduct. Targeted Ther."},{"key":"2214_CR8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41392-024-02035-4","volume":"9","author":"X Sun","year":"2024","unstructured":"Sun, X., Setrerrahmane, S., Li, C., Hu, J. & Xu, H. Nucleic acid drugs: recent progress and future perspectives. Signal Transduct. Targeted Ther. 9, 316 (2024).","journal-title":"Signal Transduct. Targeted Ther."},{"key":"2214_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nbt.3765","volume":"35","author":"A Khvorova","year":"2017","unstructured":"Khvorova, A. & Watts, J. K. The chemical evolution of oligonucleotide therapies of clinical utility. Nat. Biotechnol. 35, 238 (2017).","journal-title":"Nat. Biotechnol."},{"key":"2214_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.omtn.2016.12.003","volume":"6","author":"Y Huang","year":"2017","unstructured":"Huang, Y. Preclinical and clinical advances of GalNAc-decorated nucleic acid therapeutics. Mol. Ther. Nucleic Acids 6, 116\u2013132 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2214_CR11","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1021\/bc200422w","volume":"23","author":"M Raouane","year":"2012","unstructured":"Raouane, M., Desma\u00eble, D., Urbinati, G., Massaad-Massade, L. & Couvreur, P. Lipid conjugated oligonucleotides: a useful strategy for delivery. Bioconjug. Chem. 23, 1091\u20131104 (2012).","journal-title":"Bioconjug. Chem."},{"key":"2214_CR12","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.1093\/nar\/gkw236","volume":"44","author":"RL Juliano","year":"2016","unstructured":"Juliano, R. L. The delivery of therapeutic oligonucleotides. Nucleic Acids Res. 44, 6518\u20136548 (2016).","journal-title":"Nucleic Acids Res."},{"key":"2214_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1089\/nat.2017.0716","volume":"28","author":"L Johannes","year":"2018","unstructured":"Johannes, L. & Lucchino, M. Current challenges in delivery and cytosolic translocation of therapeutic RNAs. Nucleic Acid Ther. 28, 178\u2013193 (2018).","journal-title":"Nucleic Acid Ther."},{"key":"2214_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-021-00898-0","volume":"16","author":"JA Kulkarni","year":"2021","unstructured":"Kulkarni, J. A. et al. The current landscape of nucleic acid therapeutics. Nat. Nanotechnol. 16, 630\u2013643 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"2214_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts, T. C., Langer, R. & Wood, M. J. A. Advances in oligonucleotide drug delivery. Nat. Rev. Drug Discov. 19, 673\u2013694 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2214_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1021\/ar00009a005","volume":"24","author":"MH Caruthers","year":"1991","unstructured":"Caruthers, M. H. Chemical synthesis of DNA and DNA analogs. Acc. Chem. Res. 24, 278\u2013284 (1991).","journal-title":"Acc. Chem. Res."},{"key":"2214_CR17","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/S0040-4039(01)90461-7","volume":"22","author":"SL Beaucage","year":"1981","unstructured":"Beaucage, S. L. & Caruthers, M. H. Deoxynucleoside phosphoramidites\u2014a new class of key intermediates for deoxypolynucleotide synthesis. Tetrahedron Lett. 22, 1859\u20131862 (1981).","journal-title":"Tetrahedron Lett."},{"key":"2214_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0076-6879(87)54081-2","volume":"154","author":"MH Caruthers","year":"1987","unstructured":"Caruthers, M. H. et al. Chemical synthesis of deoxyoligonucleotides by the phosphoramidite method. Methods Enzymol. 154, 287\u2013313 (1987).","journal-title":"Methods Enzymol."},{"key":"2214_CR19","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.1016\/S0040-4020(01)87958-8","volume":"49","author":"SL Beaucage","year":"1993","unstructured":"Beaucage, S. L. & Iyer, R. P. The synthesis of oligonucleotides by the phosphoramidite approach and their applications. Tetrahedron 49, 6123\u20136194 (1993).","journal-title":"Tetrahedron"},{"key":"2214_CR20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1080\/15257770.2015.1071846","volume":"34","author":"JS Hargreaves","year":"2015","unstructured":"Hargreaves, J. S., Kaiser, R. & Wolber, P. K. The degradation of dG phosphoramidites in solution. Nucleosides Nucleotides Nucleic Acids 34, 691\u2013707 (2015).","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2214_CR21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1081\/NCN-120039215","volume":"23","author":"AH Krotz","year":"2004","unstructured":"Krotz, A. H. et al. Solution stability and degradation pathway of deoxyribonucleoside phosphoramidites in acetonitrile. Nucleosides Nucleotides Nucleic Acids 23, 767\u2013775 (2004).","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"2214_CR22","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1146\/annurev-pharmtox-010818-021050","volume":"59","author":"CIE Smith","year":"2019","unstructured":"Smith, C. I. E. & Zain, R. Therapeutic oligonucleotides: state of the art. Annu. Rev. Pharmacol. Toxicol. 59, 605\u2013630 (2019).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2214_CR23","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.1016\/S0040-4039(99)01914-0","volume":"40","author":"W Wang","year":"1999","unstructured":"Wang, W., Song, Q. & Jones, R. A. Nucleoside recovery in DNA and RNA synthesis. Tetrahedron Lett. 40, 8971\u20138974 (1999).","journal-title":"Tetrahedron Lett."},{"key":"2214_CR24","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1021\/jo00087a005","volume":"59","author":"CL Scremin","year":"1994","unstructured":"Scremin, C. L., Zhou, L., Srinivasachar, K. & Beaucage, S. L. Stepwise regeneration and recovery of deoxyribonucleoside phosphoramidite monomers during solid-phase oligonucleotide synthesis. J. Org. Chem. 59, 1963\u20131966 (1994).","journal-title":"J. Org. Chem."},{"key":"2214_CR25","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1016\/S0040-4039(00)76822-5","volume":"35","author":"WKD Brill","year":"1994","unstructured":"Brill, W. K. D. Facile methods to recycle nucleosides during solid phase synthesis of oligonucleotides. Tetrahedron Lett. 35, 3041\u20133044 (1994).","journal-title":"Tetrahedron Lett."},{"key":"2214_CR26","doi-asserted-by":"publisher","first-page":"8350","DOI":"10.1002\/anie.200802077","volume":"47","author":"PME Gramlich","year":"2008","unstructured":"Gramlich, P. M. E., Wirges, C. T., Manetto, A. & Carell, T. Postsynthetic DNA modification through the copper-catalyzed azide\u2013alkyne cycloaddition reaction. Angew. Chem. Int. Ed. 47, 8350\u20138358 (2008).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2214_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1021\/acsbiomedchemau.4c00092","volume":"5","author":"D Kashyap","year":"2025","unstructured":"Kashyap, D. & Booth, M. J. Nucleic acid conjugates: unlocking therapeutic potential. ACS Bio Med Chem Au 5, 3\u201315 (2025).","journal-title":"ACS Bio Med Chem Au"},{"key":"2214_CR28","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/10717544.2019.1582730","volume":"26","author":"R Zhang","year":"2019","unstructured":"Zhang, R., Qin, X., Kong, F., Chen, P. & Pan, G. Improving cellular uptake of therapeutic entities through interaction with components of cell membrane. Drug Deliv. 26, 328\u2013342 (2019).","journal-title":"Drug Deliv."},{"key":"2214_CR29","doi-asserted-by":"publisher","first-page":"7122","DOI":"10.1021\/acs.chemrev.0c00928","volume":"121","author":"NZ Fantoni","year":"2021","unstructured":"Fantoni, N. Z., El-Sagheer, A. H. & Brown, T. A hitchhiker\u2019s guide to click-chemistry with nucleic acids. Chem. Rev. 121, 7122\u20137154 (2021).","journal-title":"Chem. Rev."},{"key":"2214_CR30","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","volume":"40","author":"HC Kolb","year":"2001","unstructured":"Kolb, H. C., Finn, M. G. & Sharpless, K. B. Click chemistry: diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. 40, 2004\u20132021 (2001).","journal-title":"Angew. Chem. Int. Ed."},{"key":"2214_CR31","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1021\/ol0610946","volume":"8","author":"J Gierlich","year":"2006","unstructured":"Gierlich, J., Burley, G. A., Gramlich, P. M. E., Hammond, D. M. & Carell, T. Click chemistry as a reliable method for the high-density postsynthetic functionalization of alkyne-modified DNA. Org. Lett. 8, 3639\u20133642 (2006).","journal-title":"Org. Lett."},{"key":"2214_CR32","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1039\/b901971p","volume":"39","author":"AH El-Sagheer","year":"2010","unstructured":"El-Sagheer, A. H. & Brown, T. Click chemistry with DNA. Chem. Soc. Rev. 39, 1388\u20131405 (2010).","journal-title":"Chem. Soc. Rev."},{"key":"2214_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1039\/a905230e","volume":"29","author":"MJ Davies","year":"2000","unstructured":"Davies, M. J., Shah, A. & Bruce, I. J. Synthesis of fluorescently labelled oligonucleotides and nucleic acids. Chem. Soc. Rev. 29, 97\u2013107 (2000).","journal-title":"Chem. Soc. Rev."},{"key":"2214_CR34","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1007\/s00216-010-4304-5","volume":"399","author":"B Juskowiak","year":"2011","unstructured":"Juskowiak, B. Nucleic acid-based fluorescent probes and their analytical potential. Anal. Bioanal. Chem. 399, 3157\u20133176 (2011).","journal-title":"Anal. Bioanal. Chem."},{"key":"2214_CR35","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41587-019-0205-0","volume":"37","author":"JF Alterman","year":"2019","unstructured":"Alterman, J. F. et al. A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system. Nat. Biotechnol. 37, 884\u2013894 (2019).","journal-title":"Nat. Biotechnol."},{"key":"2214_CR36","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1093\/nar\/gky1232","volume":"47","author":"MF Osborn","year":"2018","unstructured":"Osborn, M. F. et al. Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways. Nucleic Acids Res. 47, 1070\u20131081 (2018).","journal-title":"Nucleic Acids Res."},{"key":"2214_CR37","doi-asserted-by":"publisher","first-page":"7581","DOI":"10.1093\/nar\/gkx507","volume":"45","author":"RA Haraszti","year":"2017","unstructured":"Haraszti, R. A. et al. 5\u2032-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivo. Nucleic Acids Res. 45, 7581\u20137592 (2017).","journal-title":"Nucleic Acids Res."},{"key":"2214_CR38","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","volume":"5","author":"B Hu","year":"2020","unstructured":"Hu, B. et al. Therapeutic siRNA: state of the art. Signal Transduct. Targeted Ther. 5, 101 (2020).","journal-title":"Signal Transduct. Targeted Ther."},{"key":"2214_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/toxics7020036","volume":"7","author":"K Bian","year":"2019","unstructured":"Bian, K., Delaney, J. C., Zhou, X. & Li, D. Biological evaluation of DNA biomarkers in a chemically defined and site-specific manner. Toxics 7, 36 (2019).","journal-title":"Toxics"},{"key":"2214_CR40","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/nbt.3078","volume":"32","author":"BR Meade","year":"2014","unstructured":"Meade, B. R. et al. Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications. Nat. Biotechnol. 32, 1256 (2014).","journal-title":"Nat. Biotechnol."},{"key":"2214_CR41","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1021\/acsmedchemlett.2c00027","volume":"13","author":"ML Hammill","year":"2022","unstructured":"Hammill, M. L. et al. SiRNAs with neutral phosphate triester hydrocarbon tails exhibit carrier-free gene-silencing activity. ACS Med. Chem. Lett. 13, 695\u2013700 (2022).","journal-title":"ACS Med. Chem. Lett."},{"key":"2214_CR42","doi-asserted-by":"publisher","first-page":"29773","DOI":"10.1021\/jacs.4c11402","volume":"146","author":"D Dhara","year":"2024","unstructured":"Dhara, D. et al. Synthesis, biophysical and biological evaluation of splice-switching oligonucleotides with multiple LNA-phosphothiotriester backbones. J. Am. Chem. Soc. 146, 29773\u201329781 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"2214_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202401476","volume":"9","author":"J Jin","year":"2025","unstructured":"Jin, J., Tian, C., Chen, C., Huang, C. Z. & Zuo, H. Nucleophilic reactions of phosphorothioate oligonucleotides. Small Methods 9, 2401476 (2025).","journal-title":"Small Methods"},{"key":"2214_CR44","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1021\/acs.orglett.2c04310","volume":"25","author":"S Sarkar","year":"2023","unstructured":"Sarkar, S. & Kalek, M. Metal-free S-arylation of phosphorothioate diesters and related compounds with diaryliodonium salts. Org. Lett. 25, 671\u2013675 (2023).","journal-title":"Org. Lett."}],"container-title":["Nature Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41557-026-02214-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41557-026-02214-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41557-026-02214-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:02:16Z","timestamp":1790737336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41557-026-02214-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2214"],"URL":"https:\/\/doi.org\/10.1038\/s41557-026-02214-6","relation":{},"ISSN":["1755-4330","1755-4349"],"issn-type":[{"value":"1755-4330","type":"print"},{"value":"1755-4349","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.E.F. and L.X. are employees of Eli Lilly and may own company stock. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}